CollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on Thursday

CollPlant Biotechnologies (NASDAQ:CLGN) is projected to release its earnings data before the market opens on Thursday, April 3rd. Analysts expect CollPlant Biotechnologies to post earnings of ($0.42) per share and revenue of $0.36 million for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

CollPlant Biotechnologies (NASDAQ:CLGN) last posted its quarterly earnings results on Wednesday, March 26th. The company reported ($0.34) EPS for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.08. The company had revenue of $0.17 million during the quarter, compared to analyst estimates of $0.36 million. CollPlant Biotechnologies had a negative net margin of 2,680.00% and a negative return on equity of 77.05%. On average, analysts expect CollPlant Biotechnologies to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

CollPlant Biotechnologies Stock Down 0.4 %

Shares of CollPlant Biotechnologies stock opened at $2.57 on Wednesday. The company’s fifty day simple moving average is $3.39 and its two-hundred day simple moving average is $3.89. CollPlant Biotechnologies has a 12-month low of $2.54 and a 12-month high of $6.75. The firm has a market cap of $29.44 million, a PE ratio of -1.67 and a beta of 1.07.

Wall Street Analysts Forecast Growth

Separately, D. Boral Capital reissued a “buy” rating and issued a $14.00 target price on shares of CollPlant Biotechnologies in a research note on Thursday, March 27th.

About CollPlant Biotechnologies

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.